Last quarter (Q2 2024), PharmaTher Holdings Ltd's total revenue was C$―, a decrease of ― from the same quarter last year. In Q2, PharmaTher Holdings Ltd's net income was C$-1.06M. See PharmaTher Holdings Ltd’s key income statements, including revenue, expenses, profit, and income.

Income Statement	TTM	May 23	May 22	May 21
Total Revenue	-	-	C$ 0.00	C$ 0.00
Cost of Revenue	-	-	-	-
Gross Profit	-	-	-	-
Operating Expense	C$ 4.23M	C$ 4.01M	C$ 4.10M	C$ 2.82M
Operating Income	C$ -4.23M	C$ -4.01M	C$ -4.10M	C$ -2.82M
Net Non Operating Interest Income Expense	C$ 241.55K	C$ 206.82K	-	-
Other Income Expense	C$ 750.08K	C$ 2.61M	C$ -133.33K	C$ 5.71M
Pretax Income	C$ -4.74M	C$ -6.42M	C$ -4.24M	C$ 2.89M
Tax Provision	-	-	C$ -225.05K	C$ 225.05K
Earnings From Equity Interest Net Of Tax	-	-	-	-
Net Income Common Stockholders	C$ -4.74M	C$ -6.42M	C$ -4.01M	C$ 2.66M
Basic EPS	C$ -0.01	C$ -0.07	C$ -0.05	C$ 0.04
Diluted EPS	C$ -0.01	C$ -0.07	C$ -0.05	C$ 0.04
Basic Average Shares	C$ 88.17M	C$ 88.17M	C$ 81.11M	C$ 64.56M
Diluted Average Shares	C$ 88.17M	C$ 88.17M	C$ 81.11M	C$ 73.26M
Dividend Per Share	-	-	-	-
Total Operating Income As Reported	-	-	-	-
Reported Normalized Basic E P S	-	-	-	-
Reported Normalized Diluted E P S	-	-	-	-
Rent Expense Supplemental	-	-	-	-
Total Expenses	C$ 4.23M	C$ 4.01M	C$ 4.10M	C$ 2.82M
Net Income From Continuing And Discontinued Operation	C$ -4.74M	C$ -6.42M	C$ -4.01M	C$ 2.66M
Normalized Income	-	-	C$ -3.88M	C$ -2.60M
Interest Expense	-	-	-	-
EBIT	-	-	C$ -4.10M	C$ -2.82M
EBITDA	-	-	C$ -4.10M	C$ -2.82M

Currency in CAD

PharmaTher Holdings Ltd Earnings and Revenue History

Get More with TipRanks Premium

What's Included in PREMIUM?

Make informed decisions based on Top Analysts' activity

Know what industry insiders are buying

Get actionable alerts from top Wall Street Analysts

Find out before anyone else which stock is going to shoot up

Get powerful stock screeners & detailed portfolio analysis

Subscribe Now See Plans & Pricing